Evidence map›Paper›PMID 33364395›Full record

ArticleLaryngoscope investigative otolaryngology2020

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck.

Ethan J Harris, Julian Huang, Erin Carroll, Alarice C Lowe, Nicole G Chau, Guilherme Rabinowits, Robert Haddad, Glenn J Hanna, Tyler Haddad, Matthew Sanborn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Ethan J HarrisDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.ORCID https://orcid.org/0000-0002-8735-1959
Julian HuangDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Erin CarrollDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Alarice C LoweDepartment of Pathology Stanford University Stanford California USA.
Nicole G ChauBC Cancer, Vancouver British Columbia Canada.
Guilherme RabinowitsDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Robert HaddadDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Glenn J HannaDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Tyler HaddadDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Matthew SanbornDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Alec KacewDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Jochen LorchDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Dana-Farber Cancer Institute · USBaptist Hospital of Miami · USBC Cancer Agency · CAStanford University · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCirculating tumors cells (CTCs) are considered an early step towards metastasis and have been linked to poor prognosis in several types of cancer. CTCs in squamous cell carcinoma of the head and neck (SCCHN) have an unclear role.

methodsIn this prospective study, patients with locally advanced or metastatic SCCHN had CTC counts assessed before starting systemic treatment using the CellSearch System. Select cases also had sequential CTC evaluation. Presence of CTCs was correlated with patient characteristics and outcomes.

resultsForty-eight patients enrolled, and 36 had evaluable clinical data and baseline CTC counts. Twenty-five patients had locally advanced disease (LAD) and 11 had metastatic disease. ≥1 CTCs were detected in six patients with LAD (24%) and four with metastatic disease (36%). On univariate analysis, smoking was associated with CTCs.

conclusionCTCs are not associated with prognosis in patients with LAD and metastatic disease; however, they are present in this patient population, and ≥1 CTCs is associated with a history of smoking. LEVEL OF EVIDENCE: 1b; individual prospective cohort study.

Indexed as

circulating tumor cellshead and neck cancersmoking

Identifiers

PMID33364395
PMCPMC7752061
OpenAlexW3096360724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.